3 cannabis articles scored below the CED clinical relevance threshold in the last 24 hours. Summaries and source links included.
Daily Digest: Last 9 Hours: Cognitive Safety Data, End-of-Life Access, and Regulatory Friction — March 05, 2026
A synthesis of 68 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyPolicyPediatricsCBD Why This Matters Clinicians treating pediatric drug-resistant epilepsy need to understand the access barriers...
Daily Digest 2026-03-05
✦ New Top items from the CED news pipeline. (82) Scientists are raising new concerns about marijuana use in teens – KPBSResearch continues to build a concerning picture around adolescent cannabis use...
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
WHY IT MATTERS: Children with drug-resistant epilepsy whose families cannot afford private prescriptions may continue to go without a treatment option that has demonstrated clinical evidence, simply because NHS commissioning has not kept pace with the legal changes already on the books. CLINICAL OVERVIEW: Drug-resistant epilepsy in children, particularly conditions like Dravet syndrome and Lennox-Gastaut syndrome, represents one of the most compelling and well-documented areas for cannabinoid-based medicine, with cannabidiol demonstrating meaningful seizure reduction in controlled clinical trials. Despite the rescheduling of cannabis-based medicines in the UK following high-profile advocacy, NHS access remains severely limited by prescribing restrictions, funding barriers, and a shortage of specialists willing to initiate treatment.
Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Clinical Takeaway Most of the current evidence on cannabinoid use in children comes from observational studies and surveys rather than controlled trials, reflecting the early and evolving state of this research. The...
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyNeurologyPediatricsCBD Why This Matters Clinicians treating children with drug-resistant epilepsy need to understand that despite...
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyPolicyPediatricsCBD Why This Matters Clinicians treating children with drug-resistant epilepsy need awareness that medical cannabis...
CED Cannabis Research Digest — February 27, 2026
Weekly cannabis medicine research digest. 46 peer-reviewed articles scored and curated by CED Clinic.
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyPolicyPediatricsCBD Why This Matters Clinicians treating children with drug-resistant epilepsy need to understand the access...